[go: up one dir, main page]

ES2042567T3 - Un procedimiento para la preparacion de un derivado de ergolina. - Google Patents

Un procedimiento para la preparacion de un derivado de ergolina.

Info

Publication number
ES2042567T3
ES2042567T3 ES87305570T ES87305570T ES2042567T3 ES 2042567 T3 ES2042567 T3 ES 2042567T3 ES 87305570 T ES87305570 T ES 87305570T ES 87305570 T ES87305570 T ES 87305570T ES 2042567 T3 ES2042567 T3 ES 2042567T3
Authority
ES
Spain
Prior art keywords
atomo
procedure
preparation
group
ergoline derivative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES87305570T
Other languages
English (en)
Inventor
Aldemio Temperilli
Enzo Brambilla
Mauro Gobbini
Maria Antonietta Cervini
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Italia SRL
Original Assignee
Farmitalia Carlo Erba SRL
Carlo Erba SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Farmitalia Carlo Erba SRL, Carlo Erba SpA filed Critical Farmitalia Carlo Erba SRL
Application granted granted Critical
Publication of ES2042567T3 publication Critical patent/ES2042567T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/02—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with hydrocarbon or substituted hydrocarbon radicals, attached in position 8
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Liquid Developers In Electrophotography (AREA)
  • Graft Or Block Polymers (AREA)
  • Developing Agents For Electrophotography (AREA)

Abstract

DERIVADOS DE ERGOLINA DE FORMULA GENERAL (I) DONDE R1 REPRESENTA UN ATOMO DE HIDROGENO O UN GRUPO METOXI Y R2 REPRESENTA UN ATOMO DE HIDROGENO O R1 Y R2 TOMADOS CONJUNTAMENTE REPRESENTAN UN ENLACE QUIMICO Y R3 REPRESENTA UN ATOMO DE HIDROGENO, Y UN GRUPO NICOTINOILO SUSTITUIDO O NO SUSTITUIDO O UN GRUPO 1-OXO-2-CICLOPENTANO-3-IL; O UNA SAL ACEPTABLE FARMACEUTICAMENTE ES ACTIVA A NIVEL DEL SISTEMA NERVIOSO CENTRAL Y POR ESO ES UTIL HABITUALMENTE EN EL TRATAMIENTO DE LA INSUFICIENCIA CEREBRAL Y EN LA DEMENCIA SENIL.
ES87305570T 1986-06-25 1987-06-23 Un procedimiento para la preparacion de un derivado de ergolina. Expired - Lifetime ES2042567T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB868615471A GB8615471D0 (en) 1986-06-25 1986-06-25 T-butyl ergoline derivatives

Publications (1)

Publication Number Publication Date
ES2042567T3 true ES2042567T3 (es) 1993-12-16

Family

ID=10600059

Family Applications (1)

Application Number Title Priority Date Filing Date
ES87305570T Expired - Lifetime ES2042567T3 (es) 1986-06-25 1987-06-23 Un procedimiento para la preparacion de un derivado de ergolina.

Country Status (20)

Country Link
US (2) US4843073A (es)
EP (1) EP0251652B1 (es)
JP (1) JPH0745498B2 (es)
KR (1) KR950008970B1 (es)
AT (1) ATE76407T1 (es)
AU (1) AU597672B2 (es)
CA (1) CA1339533C (es)
DE (1) DE3779190D1 (es)
DK (1) DK170099B1 (es)
ES (1) ES2042567T3 (es)
FI (1) FI85702C (es)
GB (1) GB8615471D0 (es)
GR (1) GR3005115T3 (es)
HU (1) HU196201B (es)
IE (1) IE61319B1 (es)
IL (1) IL82946A (es)
NZ (1) NZ220543A (es)
PT (1) PT85152B (es)
SU (1) SU1547708A3 (es)
ZA (1) ZA874569B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61245164A (ja) * 1985-04-23 1986-10-31 Seiko Instr & Electronics Ltd パタ−ン修正装置
HU193782B (en) * 1985-06-21 1987-11-30 Richter Gedeon Vegyeszet Process for producing 2-halogeno-nicergoline derivatives and acid additional salts thereof
US6060483A (en) * 1996-06-27 2000-05-09 Pharmacia & Upjohn S.P.A. Antineurodegenerative ergoline derivatives
WO2014195849A2 (en) * 2013-06-03 2014-12-11 Mahesh Kandula Compositions and methods for the treatment of cerebrovascular diseases

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3228945A (en) * 1966-01-11 Methyl and i,g-dimethyl-b-(a-hydroxy- alkyl)-ergoline i derivatives
US3228942A (en) * 1966-01-11 Methyl and i,g-dimeti-iyl ergoline i compounds
US3228941A (en) * 1966-01-11 Methyl and i,g-dimethyl-ergoline i derivatives
DE203721C (es) * 1908-05-05
US3232942A (en) * 1964-06-02 1966-02-01 Sandoz Ltd 1-substituted (+)-lysergol
US3879554A (en) * 1970-03-20 1975-04-22 Farmaceutici Italia Use of 1,6-dimethyl-8-{62 -(5-bromonicotinoyloxymethyl)-10 {60 -methoxyergoline in treating cerebral and peripheral metabolic vascular disorders
USRE30218E (en) * 1974-12-06 1980-02-19 Eli Lilly And Company 8,8-Disubstituted-6-methylergolines and related compounds
US3959288A (en) * 1974-12-13 1976-05-25 Eli Lilly And Company 8-Oxymethylergolines and process therefor
US4199579A (en) * 1975-03-14 1980-04-22 Siphar S. A. Carbamates of 2-haloergolines and 2-haloergolenes and process for the preparation thereof
DE2656344A1 (de) * 1975-12-23 1977-07-07 Sandoz Ag Ergolinderivate, ihre verwendung und herstellung
IT1192260B (it) * 1977-07-05 1988-03-31 Simes Derivati di ergoline-2-tioeteri e loro solfossidi
GB2056437A (en) * 1979-08-07 1981-03-18 Erba Farmitalia Secoergoline derivatives
US4382940A (en) * 1979-12-06 1983-05-10 Farmitalia Carlo Erba S.P.A. Ercoline derivatives and therapeutic compositions having CNS affecting activity
DE3403067A1 (de) * 1984-01-30 1985-08-14 Eckart Prof. Dr. 6500 Mainz Eich Ergolin-derivate, verfahren zu ihrer herstellung, sie enthaltende arzneimittel und deren verwendung
IT1213206B (it) * 1984-08-07 1989-12-14 Inverni Della Beffa Spa Procedimento per la preparazione di derivati del lisergolo.
GB8612366D0 (en) * 1986-05-21 1986-06-25 Erba Farmitalia Ergoline esters
AU7914587A (en) * 1987-08-24 1989-03-31 Molecular Control Corporation Liquid crystal micelles, display, having concentric spheres

Also Published As

Publication number Publication date
KR880000429A (ko) 1988-03-25
AU7463287A (en) 1988-01-07
EP0251652A2 (en) 1988-01-07
HU196201B (en) 1988-10-28
FI85702C (fi) 1992-05-25
EP0251652A3 (en) 1989-04-05
GR3005115T3 (es) 1993-05-24
CA1339533C (en) 1997-11-11
IE871652L (en) 1987-12-25
FI872752A0 (fi) 1987-06-22
AU597672B2 (en) 1990-06-07
NZ220543A (en) 1989-06-28
KR950008970B1 (ko) 1995-08-10
PT85152B (pt) 1990-03-30
DE3779190D1 (de) 1992-06-25
PT85152A (en) 1987-07-01
US5079364A (en) 1992-01-07
EP0251652B1 (en) 1992-05-20
JPS6322577A (ja) 1988-01-30
ZA874569B (en) 1988-02-24
DK322587A (da) 1987-12-26
US4843073A (en) 1989-06-27
JPH0745498B2 (ja) 1995-05-17
DK170099B1 (da) 1995-05-22
ATE76407T1 (de) 1992-06-15
DK322587D0 (da) 1987-06-24
FI872752L (fi) 1987-12-26
IE61319B1 (en) 1994-11-02
IL82946A (en) 1991-04-15
GB8615471D0 (en) 1986-07-30
SU1547708A3 (ru) 1990-02-28
HUT44543A (en) 1988-03-28
IL82946A0 (en) 1987-12-20
FI85702B (fi) 1992-02-14

Similar Documents

Publication Publication Date Title
HUT43582A (en) Process for production of derivatives of 4,5,6-substituated-n-/substituated phenil/-piramidin-amin and medical compounds containing thereof
MX173308B (es) Procedimiento para la preparacion de indolinas 3,3-disustuidas
ES2164889T3 (es) Semicarbazonas con actividad sobre el snc y preparados farmaceuticos a base de las mismas.
DE3686622D1 (de) Verwendung von dioxopiperidin-derivaten zur behandlung von anxietas, zur herabsetzung von chronischen abnormal hohen gehirn-spiegeln serotonins oder 5-hydroxy-indolessigsaeure und zur behandlung von bakteriellen oder viralen infektionen.
NO166362C (no) Analogifremgangsmaate for fremstilling av nye terapeutisk aktive polyaminderivater.
ES2054723T3 (es) Tetrahidropiridinoximas, procedimiento para su preparacion y uso de las mismas como agentes colinergicos.
DE3764724D1 (de) 2-phenylbenzoxepin-derivat.
ES525786A0 (es) Un procedimiento para preparar derivados de pirazolo (3,4-b) piridina
DK217588D0 (da) 17beta-(cyclopropylamino)-androst-5-en-3beta-olderivater, deres fremstilling og anvendelse som laegemidler
FR2355826A1 (fr) Procede de preparation du chlorhydrate de 2,6-xylylide de l'acide n-methyl-piperidine-2-carboxylique
ES2042567T3 (es) Un procedimiento para la preparacion de un derivado de ergolina.
NO170886C (no) Analogifremgangsmaate for fremstilling av nye terapeutisk aktive benzotiofener
EP1413299A3 (en) Use of deprenyl analogues to maintain, prevent loss, or recover nerve cell function
EP0319962A3 (en) Piperidinyl methanol derivatives for the treatment of anxiety
ATE69049T1 (de) Chinazolin-derivat, verfahren zu dessen herstellung und mittel zur behandlung von cerebraler disfunktion als aktiver inhaltsstoff.
NO894445L (no) Fremgangsmaate for fremstilling av 1,2,3,4-tetrahydro-1,9-acridindiaminer, og deres anvendelse som medikamenter.
NO864635D0 (no) Nye krystallinske salter av aryloksyfenolaminer og deres fremstilling.
ES2081834T3 (es) Pirrolidin-2-onas 4-metil y 4-etil sustituidas.
GR3017198T3 (en) Process for modification of a molecular sieve.
KR880001596A (ko) 디하이드로피리딘 화합물-함유 뇌기능이상 치료제
ES8304572A2 (es) "mejoras introducidas en el objeto de la patente principal n 503.050, solicitada el 15 de junio de 1981, por:un procedimiento para recuperar cafeina desde carbono activado".
EP0249761A3 (en) Ergoline esters, a process for their preparation and pharmaceutical compositions containing them
AU7720587A (en) Substituted hexahydroarylquinolizines
DK65691A (da) 2-aminocarboxylsyre-derivater, deres fremstilling og anvendelse som laegemidler
SE8305362D0 (sv) Novel substituted phenylazacycloalkanes, processes for preparation and pharmaceutical preparations for such compounds

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 251652

Country of ref document: ES